Metabolic Encephalopathy
Editat de David W. McCandlessen Limba Engleză Paperback – 11 dec 2011
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1062.93 lei 39-44 zile | |
| Springer – 11 dec 2011 | 1062.93 lei 39-44 zile | |
| Hardback (1) | 1236.19 lei 6-8 săpt. | |
| Springer – 9 sep 2008 | 1236.19 lei 6-8 săpt. |
Preț: 1062.93 lei
Preț vechi: 1398.59 lei
-24% Nou
Puncte Express: 1594
Preț estimativ în valută:
203.41€ • 212.63$ • 171.89£
203.41€ • 212.63$ • 171.89£
Carte tipărită la comandă
Livrare economică 03-08 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781441927125
ISBN-10: 1441927123
Pagini: 620
Ilustrații: XVI, 601 p.
Dimensiuni: 155 x 235 x 33 mm
Greutate: 0 kg
Ediția:2009
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1441927123
Pagini: 620
Ilustrații: XVI, 601 p.
Dimensiuni: 155 x 235 x 33 mm
Greutate: 0 kg
Ediția:2009
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
V-ar putea interesa
-
Preț: 312.07 lei -
The Visual (Un)Conscious and Its (Dis)Contents: A microtemporal approachBruno G. Breitmeyer-31%Preț: 326.49 lei474.73 lei -
Surrounding Free Will: Philosophy, Psychology, NeuroscienceAlfred R. Mele-30%Preț: 523.41 lei748.92 lei -
-30%Preț: 498.97 lei709.34 lei -
-24%Preț: 468.48 lei612.94 lei -
-27%Preț: 675.29 lei924.41 lei -
Collective EmotionsChristian von Scheve-25%Preț: 694.82 lei927.31 lei -
Emotion and Decision-making ExplainedEdmund T. Rolls-22%Preț: 409.74 lei522.47 lei -
Aesthetics and the Sciences of MindGreg Currie-26%Preț: 528.98 lei714.85 lei -
The Brain Supremacy: Notes from the frontiers of neuroscienceKathleen TaylorPreț: 127.30 lei -
Metabolic Basis of ObesityRexford S. Ahima-5%Preț: 784.85 lei826.16 lei -
-15%Preț: 656.58 lei772.44 lei -
-18%Preț: 1125.23 lei1372.23 lei -
-18%Preț: 952.26 lei1161.29 lei
Public țintă
ResearchDescriere
Metabolic Encephalopathy is meant to combine and correlate animal and human studies. In many cases, alterations in the neurochemistry of humans and experimental animal models is similar. It is hoped that increased awareness of the importance of early diagnosis and treatment of these disorders may result in a lowering of the incidence of structural changes and morbidity. These metabolic encephalopathies hold a special fascination for both basic scientists and clinical investigators because they are accessible, treatable, and there exist good animal models for further study. Therefore, this book assembles both basic and clinical neuroscience issues in the treatment of specific metabolic encephalopathies such as uremia, Wernicke’s disease, epilepsy, stroke, hepatic encephalopathy, pediatric encephalopathies, inborn errors of metabolism, toxins such as lead, depression, cerebral infections, kernicterus, Wilson disease, and many others.
About the Editor:
Dr. David W. McCandless is the John J. Sheinin Professor of Anatomy in the Department of Cell Biology and Anatomy at The Chicago Medical School, Rosalind Franklin University, North Chicago, IL. He has over 35 years of laboratory research into basic mechanisms of various metabolic encephalopathies. He serves as Editor-in Chief of the journal Metabolic Brain Disease (Springer), now in its 23rd year. Dr. McCandless has been on the faculty or research staff at The University of Vermont College of Medicine, NIH-NINCDS, University of Texas Medical School at Houston, and The Chicago Medical School, and was a visiting professor at Washington University School of Medicine. Dr. McCandless has published in journals such as The J. Clinical Investigation, Nature, Proc. National Academy of Sciences, Amer. J. of Physiology, Brain Research, J. Neurochemistry, Teratology, Epilepsia, Stroke, and many others. This is his third edited book.
About the Editor:
Dr. David W. McCandless is the John J. Sheinin Professor of Anatomy in the Department of Cell Biology and Anatomy at The Chicago Medical School, Rosalind Franklin University, North Chicago, IL. He has over 35 years of laboratory research into basic mechanisms of various metabolic encephalopathies. He serves as Editor-in Chief of the journal Metabolic Brain Disease (Springer), now in its 23rd year. Dr. McCandless has been on the faculty or research staff at The University of Vermont College of Medicine, NIH-NINCDS, University of Texas Medical School at Houston, and The Chicago Medical School, and was a visiting professor at Washington University School of Medicine. Dr. McCandless has published in journals such as The J. Clinical Investigation, Nature, Proc. National Academy of Sciences, Amer. J. of Physiology, Brain Research, J. Neurochemistry, Teratology, Epilepsia, Stroke, and many others. This is his third edited book.
Cuprins
Preface. David.W. McCandless.- 1. Functional Anatomy of the Brain. John M. DeSesso.- 2. Brain Metabolic Adaptations to Hypoxia. Michelle A. Puchowicz, Smruta S. Koppaka, and Joseph C. LaManna.- 3. Hypoglycemic Brain Damage.- Roland N. Auer.- 4. Experimental Ischemia: Summary of Metabolic Encephalopathy. W. David Lust, Jennifer Zechel, and Svetlana Pundik.- 5. Stroke—Clinical Features. Svetlana Pundik, and Jose I. Suarez.- 6. The Role of Animal Models in the Study of Epileptogenesis. Kate Chandler, Pi-Shan Chang, and Matthew Walker.- 7. Seizure-Induced Neuronal Plasticity and Metabolic Effects. Monisha Goyal.- 8. Metabolic Encephalopathies in Children. Joseph DiCarlo.- 9. Pathophysiology of Hepatic Encephalopathy: Studies in Animal Models. Roger F. Butterworth.- 10. Hepatic Encephalopathy. Karin Weissenborn.- 11. Uremic and Dialysis Encephalopathies. Allen I. Arieff.- 12. Thiamine Deficiency: A Model of Metabolic Encephalopathy and of Selective Neuronal Vulnerability. Saravanan Karuppagounder and Gary E. Gibson.- 13. Alcohol, Apoptosis, and Oxidative Stress. George I Henderson, Jennifer Stewart, and Steven Schenker.- 14. Wernicke’s Encephalopathy. Maryam R. Kashi, George I Henderson, and Steven Schenker.- 15. The Genetics of Myelination in Metabolic Brain Disease: The Leukodystrophies. John W. Rumsey.- 16. Bilirubin Encephalopathy. Jeffrey W. McCandless and David W McCandless.- 17. Infectious And Inflammatory Metabolic Encephalopathies: Concepts in Pathogenesis. Kottil Rammohan.- 18. Major Depression and Metabolic Encephalopathy: Syndromes More Alike Than Not? Brian H. Harvey.- 19. Attention-deficit/hyperactivity Disorder as a Metabolic Encephalopathy. Vivienne Ann Russell.- 20. Brain Damage in Phenylalanine, Homocysteine, and Galactose Metabolic Disorders. Kleopatra H.Schulpis and Stylianos Tsakiris.- 21. Wilson Disease. Peter Ferenci.- 22. Metabolic Abnormalities in Alzheimer Disease. Florian M. Gebhardt and Peter R Dodd.- 23. Prions and the Transmissible Spongiform Encephalopathies. Richard C. Wiggins.- 24. Lead Encephalopathy. Ivan J. Boyer.- Index.
Recenzii
From the reviews:
"This book summarises a wealth of information on several neurological disorders from animal models to human conditions … . This approach provides the book with a useful role for continuous education of general neurologists and for introducing neurological diseases to trainees in a modern way. … this book helps to increase awareness of the importance of early diagnosis and treatment of these disorders, which can reduce the incidence of structural brain changes and morbidity." (Antonio Federico, The Lancet Neurology, Vol. 8, August, 2009)
"This book summarises a wealth of information on several neurological disorders from animal models to human conditions … . This approach provides the book with a useful role for continuous education of general neurologists and for introducing neurological diseases to trainees in a modern way. … this book helps to increase awareness of the importance of early diagnosis and treatment of these disorders, which can reduce the incidence of structural brain changes and morbidity." (Antonio Federico, The Lancet Neurology, Vol. 8, August, 2009)
Textul de pe ultima copertă
Metabolic Encephalopathy is meant to combine and correlate animal and human studies. In many cases, alterations in the neurochemistry of humans and experimental animal models is similar. It is hoped that increased awareness of the importance of early diagnosis and treatment of these disorders may result in a lowering of the incidence of structural changes and morbidity. These metabolic encephalopathies hold a special fascination for both basic scientists and clinical investigators because they are accessible, treatable, and there exist good animal models for further study. Therefore, this book assembles both basic and clinical neuroscience issues in the treatment of specific metabolic encephalopathies such as uremia, Wernicke’s disease, epilepsy, stroke, hepatic encephalopathy, pediatric encephalopathies, inborn errors of metabolism, toxins such as lead, depression, cerebral infections, kernicterus, Wilson disease, and many others.
About the Editor:
Dr. David W. McCandless is the John J. Sheinin Professor of Anatomy in the Department of Cell Biology and Anatomy at The Chicago Medical School, Rosalind Franklin University, North Chicago, IL. He has over 35 years of laboratory research into basic mechanisms of various metabolic encephalopathies. He serves as Editor-in Chief of the journal Metabolic Brain Disease (Springer), now in its 23rd year. Dr. McCandless has been on the faculty or research staff at The University of Vermont College of Medicine, NIH-NINCDS, University of Texas Medical School at Houston, and The Chicago Medical School, and was a visiting professor at Washington University School of Medicine. Dr. McCandless has published in journals such as The J. Clinical Investigation, Nature, Proc. National Academy of Sciences, Amer. J. of Physiology, Brain Research, J. Neurochemistry, Teratology, Epilepsia, Stroke, and many others. This is his third edited book.
About the Editor:
Dr. David W. McCandless is the John J. Sheinin Professor of Anatomy in the Department of Cell Biology and Anatomy at The Chicago Medical School, Rosalind Franklin University, North Chicago, IL. He has over 35 years of laboratory research into basic mechanisms of various metabolic encephalopathies. He serves as Editor-in Chief of the journal Metabolic Brain Disease (Springer), now in its 23rd year. Dr. McCandless has been on the faculty or research staff at The University of Vermont College of Medicine, NIH-NINCDS, University of Texas Medical School at Houston, and The Chicago Medical School, and was a visiting professor at Washington University School of Medicine. Dr. McCandless has published in journals such as The J. Clinical Investigation, Nature, Proc. National Academy of Sciences, Amer. J. of Physiology, Brain Research, J. Neurochemistry, Teratology, Epilepsia, Stroke, and many others. This is his third edited book.
Caracteristici
Considers both animal and human studies, and integrates them into statements of mechanisms and biochemical alterations and treatments
Contains the most commonly seen metabolic encephalopathies and those in which the diagnosis and treatment have advanced and benefited from technological studies
Will be of interest to both researchers and clinicians
Contains the most commonly seen metabolic encephalopathies and those in which the diagnosis and treatment have advanced and benefited from technological studies
Will be of interest to both researchers and clinicians